Clover Health Investments Corp (DE:7QD)
NASDAQ:7QD
7QD Stock Chart & Stats
€1.79
€0.23(7.23%)
At close: 4:00 PM EST
€1.79
€0.23(7.23%)
Day’s Range― - ―
52-Week Range€1.41 - €4.92
Previous CloseN/A
Volume0.00
Average Volume (3M)663.00
Market Cap
€2.15B
Enterprise Value€1.89B
Total Cash (Recent Filing)€177.56M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.68
Next Earnings
Aug 10, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding430,969,400
10 Day Avg. Volume230
30 Day Avg. Volume663
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)3.94
Price to Sales (P/S)0.63
P/FCF Ratio-17.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.87Price Target Upside116.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.03
Revenue Forecast (FY)€2.50B
Bulls Say, Bears Say
Bulls Say
Rapid MA Membership And Revenue GrowthSustained rapid member growth and strong revenue expansion increase predictable capitation cashflows and create scale benefits. As cohorts mature, fixed SG&A dilutes, network leverage improves unit economics and accelerates margin expansion, supporting durable insurer profitability if managed consistently.
Conservative Balance Sheet With No DebtNear-zero leverage and a sizeable cash position provide financial flexibility to self-fund growth, invest in provider networks and technology, and absorb medical cost variability. This lowers insolvency risk and supports long-term execution of Medicare Advantage expansion strategies.
Clinical Tech Adoption And Care Management ScaleRapid adoption of Clover Assistant and home‑based care deepens clinical integration, enabling better utilization management and differentiation. Platform-driven care coordination can sustainably reduce medical costs per member and supports both insurance margins and future SaaS monetization.
Bears Say
Profitability Still Uneven And MarginalAlthough recent quarters show improvement, persistent negative net margins indicate the company has not yet sustainably converted scale into durable profitability. Continued dependence on cohort maturation and cost controls creates execution risk to consistent long‑term returns.
Elevated Outpatient Utilization & Part D RiskRising outpatient use increases claim costs and compresses the insurer spread. Simultaneously, Part D dynamics and risk‑adjustment normalization introduce revenue variability from CMS payments. Both factors can structurally pressure margins and complicate multi-year forecasting.
Cash Flow Volatility And Cohort Maturation RiskRecent positive cash generation is promising but historical volatility underscores execution risk. New member cohorts take time to mature; inconsistent cash flow could constrain reinvestment in care programs or force tradeoffs during adverse utilization periods, limiting long‑term margin resilience.
Clover Health Investments News
7QD FAQ
What was Clover Health Investments Corp’s price range in the past 12 months?
Clover Health Investments Corp lowest stock price was €1.41 and its highest was €4.92 in the past 12 months.
What is Clover Health Investments Corp’s market cap?
Clover Health Investments Corp’s market cap is €2.15B.
When is Clover Health Investments Corp’s upcoming earnings report date?
Clover Health Investments Corp’s upcoming earnings report date is Aug 10, 2026 which is in 55 days.
How were Clover Health Investments Corp’s earnings last quarter?
Clover Health Investments Corp released its earnings results on May 06, 2026. The company reported €0.062 earnings per share for the quarter, beating the consensus estimate of €0.059 by €0.003.
Is Clover Health Investments Corp overvalued?
According to Wall Street analysts Clover Health Investments Corp’s price is currently Undervalued.
Does Clover Health Investments Corp pay dividends?
Clover Health Investments Corp does not currently pay dividends.
What is Clover Health Investments Corp’s EPS estimate?
Clover Health Investments Corp’s EPS estimate is 0.03.
How many shares outstanding does Clover Health Investments Corp have?
Clover Health Investments Corp has 430,969,400 shares outstanding.
What happened to Clover Health Investments Corp’s price movement after its last earnings report?
Clover Health Investments Corp reported an EPS of €0.062 in its last earnings report, beating expectations of €0.059. Following the earnings report the stock price went up 11.009%.
Which hedge fund is a major shareholder of Clover Health Investments Corp?
Currently, no hedge funds are holding shares in DE:7QD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clover Health Investments Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€3.87 (116.16% Upside)
€3.87 (116.16% Upside)
Blogger Sentiment
Bullish
DE:7QD Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €497.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 9%
Bearish news 9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.43%
12-Months-Change
Fundamentals
Return on Equity
-17.08%
Trailing 12-Months
Asset Growth
19.53%
Trailing 12-Months
Company Description
Clover Health Investments Corp
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
7QD Company Deck
7QD Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong set of operational and financial positives: rapid membership growth (~51% YoY), significant revenue growth (+62% YoY), improved gross profit (+47% YoY), GAAP profitability ($27M) and expanding clinical engagement (Clover Assistant reach and Clover Care enrollment up ~90%). Management acknowledged elevated outpatient utilization, Part D and prior-period reserve variability and one-time SG&A items, but described concrete actions (AI/data, dental cost controls, targeted remediation) and emphasized disciplined monitoring. Given the magnitude and breadth of the favorable metrics and the balance of challenges being described as manageable or being actively addressed, the overall tone is optimistic and confidence-driven while cautious on cohort maturation risks.View all DE:7QD earnings summaries7QD Stock 12 Month Forecast
Average Price Target
€3.87
▲(116.16% Upside)
Technical Analysis
Options Prices
Currently, No data available
---